The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 10th 2025
Don’t be asleep at the wheel. AI is coming, and it’s coming fast.
Regulatory Committee Advises Against Approval of Actavis' Hypertension Treatment
September 11th 2014The FDA's Cardiovascular and Renal Drugs Advisory Committee has recommended against the approval of Actavis' fixed-dose combination of nebivolol and valsartan for the treatment of hypertension.
Read More